Pharmacologic treatments for covid-19 patients
Hydroxychlrooquine+ Sofosbuvir vs Hydroxychloroquine + lopinavir + ritonavir
This comparison will not be updated. Last search date 28 Feb, 2022.
Hospitalized patients
Forest plots
(last update: 2021-03-11)
To access all information :
- click here for Hospitalized patients
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=244
Back to your research
Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
---|---|---|---|---|---|---|---|---|
Treatment 1 | Treatment 2 | |||||||
N/A Sali S, Novelty in Biomedici, 2021 Full text |
Public/non profit |
Hydroxychloroquine+Sofosbuvir |
Hydroxychloroquine+Lopinavir-Ritonavir |
RCT | Patients with confirmed COVID-19 (moderate-severe) admitted to a single center in Iran | N=54 |
Some concerns Details |